Science is only as powerful as the way it is communicated
In today's complex healthcare and life sciences ecosystem, organizations need more than content. They need a clinician-led partner who turns dense clinical and scientific data into clarity, credibility, and decisions that stand up to scrutiny, from the study protocol to the regulator and the payer.
Who We Are
EvySaif is a specialized, clinician-led medical, scientific, and regulatory consultancy based in Pune, India, serving pharmaceutical, biotech, medical device, and healthcare organizations across India, the Middle East, Europe, and beyond. We exist to bridge the gap between evidence and engagement, taking the data your teams generate and shaping it into the documents, regulatory submissions, strategies, and communications that are scientifically accurate, compliant, and genuinely useful to the people who read them.
What sets us apart begins with how we are led. EvySaif was founded and is led by Dr Idris Dawaiwala, a qualified clinician with hands-on hospital clinical experience spanning infectious disease, oncology, analgesia, critical care, and precision medicine, alongside a record of peer-reviewed publications. That means your work is not just written to a template. It is shaped by someone who has practiced at the bedside, interpreted clinical evidence under real conditions, and understands what a regulator, a payer, a journal reviewer, or a treating physician actually needs to see. This clinical grounding runs through everything we produce and is the reason our documents read as sound science, not just polished text.
We work as an extension of your team, whether you need a single deliverable or an integrated evidence and submission program spanning many. We adapt to your templates, your timelines, and your target markets, and we hold every deliverable to the same standard regardless of size. EvySaif is one of the best research and medical writing consultancies in India, and we bring that standard to every engagement, for the smallest abstract and the largest regulatory dossier alike.
What We Do
Our work spans the full evidence and regulatory lifecycle, from designing a study to securing approval and making the case for a product, organized across connected service areas. Because the same clinical and scientific team stands behind all of them, your evidence stays consistent as it moves from one to the next.
Scientific, Medical, and Regulatory Writing and Consultancy
Regulatory, clinical, and device documents written to international standards, including clinical trial protocols and synopses, clinical study reports (CSRs) to ICH E3, pharmacovigilance and aggregate safety reports (DSUR, PSUR and PBRER), and CTD and eCTD submission summaries. We also provide regulatory consultancy and submission support across all major regulated markets, aligned with the requirements of the US FDA, the EMA, the MHRA, CDSCO (under the New Drugs and Clinical Trials Rules), the SFDA, the UAE health authorities (MOHAP, the Department of Health Abu Dhabi, and the DHA Dubai), the TGA, Health Canada, the PMDA, and the NMPA, covering CTD and eCTD dossier preparation, regulatory strategy, lifecycle maintenance, regulatory intelligence, and responses to authority queries.
Health Economics and Outcomes Research (HEOR)
Cost-effectiveness and budget impact modeling, systematic literature reviews and meta-analysis, real-world evidence and outcomes research, and global value dossiers, reported to standards such as CHEERS 2022 and PRISMA 2020 and built to support health technology assessment (HTA), pricing, and market access.
Publications and Research Support
Manuscripts, abstracts, posters, and publication planning, built on rigorous evidence synthesis and prepared to Good Publication Practice (GPP) and the standards that peer-reviewed journals and congresses expect.
Scientific Communication and Engagement
Medical education content, congress and symposia materials, scientific slide decks, and narratives that translate complex data into the right message for the right audience.
Medical Affairs Solutions
Medical information and standard response documents, advisory board planning and reporting, field medical and MSL enablement content, medical review for scientific accuracy, and medical affairs strategy, all delivered as non-promotional, compliant scientific exchange.
Whether you engage us for one deliverable or an end-to-end program, the science holds together across all of it.
Why EvySaif
Clinician-led at the core
Your work is handled and reviewed by a qualified clinician with direct clinical experience across infectious disease, oncology, analgesia, critical care, and precision medicine, so the clinical substance is sound, not just the formatting. This is the difference between a document that reads well and one that holds up when a regulator, payer, or reviewer examines it closely.
A genuine track record, not just capability
Our team has authored first-in-human clinical trial protocols, prepared regulatory submission documents and IVD performance evaluation files for Indian and European markets, built health economic models rigorous enough for peer-reviewed publication, and delivered oncology advisory board programs end to end. We speak from delivered work, not theory.
Built to recognized standards
We write and advise to the frameworks that regulators, payers, and journals actually expect, including ICH guidelines (GCP, safety, and quality), Good Pharmacovigilance Practices (GVP), CHEERS 2022, PRISMA 2020, the EU IVDR and MDR, and India's CDSCO requirements. Standards are the starting point of our work, not an afterthought.
Made for your market, across regions
With direct experience across India, the Middle East, Europe, and other regulated markets, we adapt every deliverable to the regulatory and payer reality of where you operate. This matters more each year as Gulf and Indian requirements continue to formalize, from mandatory economic evaluation in Saudi Arabia to evolving marketing and compliance codes in India.
Honest and rigorous
We give you clear, critical input rather than easy validation, targeted edits over cosmetic rewrites, and documents designed to withstand scrutiny from the people who review them. If something in your evidence, benefit-risk argument, or submission does not hold, we tell you before your reviewers do.
One partner across the lifecycle
Because we cover regulatory affairs, scientific and medical writing, medical affairs, and health economics under one roof, your evidence, strategy, submissions, and communications stay aligned instead of fragmented across multiple vendors. One team, one standard, one consistent scientific story from protocol to approval to market access.